Literature DB >> 27764728

HPV31 utilizes the ATR-Chk1 pathway to maintain elevated RRM2 levels and a replication-competent environment in differentiating Keratinocytes.

Daniel C Anacker1, Heather L Aloor2, Caitlin N Shepard3, Gina M Lenzi3, Bryan A Johnson1, Baek Kim4, Cary A Moody5.   

Abstract

Productive replication of human papillomaviruses (HPV) is restricted to the uppermost layers of the differentiating epithelia. How HPV ensures an adequate supply of cellular substrates for viral DNA synthesis in a differentiating environment is unclear. Here, we demonstrate that HPV31 positive cells exhibit increased dNTP pools and levels of RRM2, a component of the ribonucleotide reductase (RNR) complex, which is required for de novo synthesis of dNTPs. RRM2 depletion blocks productive replication, suggesting RRM2 provides dNTPs for viral DNA synthesis in differentiating cells. We demonstrate that HPV31 regulates RRM2 levels through expression of E7 and activation of the ATR-Chk1-E2F1 DNA damage response, which is essential to combat replication stress upon entry into S-phase, as well as for productive replication. Our findings suggest a novel way in which viral DNA synthesis is regulated through activation of ATR and Chk1 and highlight an intriguing new virus/host interaction utilized for viral replication.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA damage response; Human papillomavirus; Pathogenesis; Replication

Mesh:

Substances:

Year:  2016        PMID: 27764728      PMCID: PMC5102796          DOI: 10.1016/j.virol.2016.09.028

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  76 in total

1.  Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors.

Authors:  Matilde Murga; Stefano Campaner; Andres J Lopez-Contreras; Luis I Toledo; Rebeca Soria; Maria F Montaña; Luana D' Artista; Thomas Schleker; Carmen Guerra; Elena Garcia; Mariano Barbacid; Manuel Hidalgo; Bruno Amati; Oscar Fernandez-Capetillo
Journal:  Nat Struct Mol Biol       Date:  2011-11-27       Impact factor: 15.369

2.  Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose.

Authors:  Regina Wilson; Laimonis A Laimins
Journal:  Methods Mol Med       Date:  2005

3.  S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs.

Authors:  S Björklund; S Skog; B Tribukait; L Thelander
Journal:  Biochemistry       Date:  1990-06-12       Impact factor: 3.162

4.  Controlled protein degradation regulates ribonucleotide reductase activity in proliferating mammalian cells during the normal cell cycle and in response to DNA damage and replication blocks.

Authors:  A Chabes; L Thelander
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

5.  Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.

Authors:  J Chodosh; V P Holder; Y J Gan; A Belgaumi; J Sample; J W Sixbey
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

6.  Casein kinase II phosphorylation of the human papillomavirus-18 E7 protein is critical for promoting S-phase entry.

Authors:  W M Chien; J N Parker; D C Schmidt-Grimminger; T R Broker; L T Chow
Journal:  Cell Growth Differ       Date:  2000-08

Review 7.  Causes and consequences of replication stress.

Authors:  Michelle K Zeman; Karlene A Cimprich
Journal:  Nat Cell Biol       Date:  2014-01       Impact factor: 28.824

Review 8.  Regulation in S phase by E2F.

Authors:  Arthur B Pardee; Chiang J Li; G Prem Veer Reddy
Journal:  Cell Cycle       Date:  2004-09-04       Impact factor: 4.534

Review 9.  Mitotic control of dTTP pool: a necessity or coincidence?

Authors:  Chun-Mei Hu; Zee-Fen Chang
Journal:  J Biomed Sci       Date:  2007-05-25       Impact factor: 8.410

10.  A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cells.

Authors:  Lorena Taricani; Frances Shanahan; Maria-Christina Malinao; Maribel Beaumont; David Parry
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

View more
  22 in total

Review 1.  Innate Antiviral Immunity in the Skin.

Authors:  Chelsea Handfield; Jeffery Kwock; Amanda S MacLeod
Journal:  Trends Immunol       Date:  2018-03-08       Impact factor: 16.687

Review 2.  Modulation of the DNA damage response during the life cycle of human papillomaviruses.

Authors:  Daniel C Anacker; Cary A Moody
Journal:  Virus Res       Date:  2016-11-09       Impact factor: 3.303

Review 3.  Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma.

Authors:  Pooja Karukonda; Diana Odhiambo; Yvonne M Mowery
Journal:  Mol Carcinog       Date:  2021-12-29       Impact factor: 4.784

4.  HPV 16 E7 alters translesion synthesis signaling.

Authors:  Sebastian O Wendel; Avanelle Stoltz; Xuan Xu; Jazmine A Snow; Nicholas Wallace
Journal:  Virol J       Date:  2022-10-20       Impact factor: 5.913

Review 5.  Impact of Replication Stress in Human Papillomavirus Pathogenesis.

Authors:  Cary A Moody
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

6.  Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation.

Authors:  Bouchra Kitab; Masaaki Satoh; Yusuke Ohmori; Tsubasa Munakata; Masayuki Sudoh; Michinori Kohara; Kyoko Tsukiyama-Kohara
Journal:  J Biol Chem       Date:  2019-02-12       Impact factor: 5.157

Review 7.  Integration of Human Papillomavirus Genomes in Head and Neck Cancer: Is It Time to Consider a Paradigm Shift?

Authors:  Iain M Morgan; Laurence J DiNardo; Brad Windle
Journal:  Viruses       Date:  2017-08-03       Impact factor: 5.048

Review 8.  Mechanisms by which HPV Induces a Replication Competent Environment in Differentiating Keratinocytes.

Authors:  Cary Moody
Journal:  Viruses       Date:  2017-09-19       Impact factor: 5.048

9.  Human Papillomaviruses Preferentially Recruit DNA Repair Factors to Viral Genomes for Rapid Repair and Amplification.

Authors:  Kavi Mehta; Laimonis Laimins
Journal:  MBio       Date:  2018-02-13       Impact factor: 7.867

10.  KDM6A addiction of cervical carcinoma cell lines is triggered by E7 and mediated by p21CIP1 suppression of replication stress.

Authors:  David R Soto; Christopher Barton; Karl Munger; Margaret E McLaughlin-Drubin
Journal:  PLoS Pathog       Date:  2017-10-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.